BFC Planning’s Oragenics OGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGEN
BFC Planning's OGEN Position: Q1 2026 in Review
BFC Planning sold out of Oragenics (OGEN) in Q1 2026, closing a stake of 1 share — an estimated $1 sold.
BFC Planning first reported a position in OGEN in Q2 2025 and held it in 3 quarters. The position peaked at $4 in Q2 2025. 20 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.
- BFC Planning reported no remaining Oragenics position as of Q1 2026 after selling out during the quarter.
- BFC Planning sold 1 Oragenics share in Q1 2026, an estimated $1.
- BFC Planning first reported a position in Oragenics in Q2 2025 and held it in 3 quarters.
- BFC Planning's Oragenics position peaked at $4 in Q2 2025.
- 20 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.
Based on BFC Planning's 13F filing for Q1 2026, filed 29 Oct 2026.